RCKT Rocket Pharmaceuticals4.05+0.58 (+16.7%)
RCKT Rocket Pharmaceuticals3.31+0.40 (+13.8%)
RCKT Rocket Pharmaceuticals2.36+0.03 (+1.3%)
RCKT Rocket Pharmaceuticals2.62-3.65 (-58.2%)
Premarket Decliner
RCKT Rocket Pharmaceuticals6.27-0.29-4.4%
Premarket:2.26-4.01 (-64.0%)
Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease
Business WireTue, 27-May 7:00 AM
RCKT Rocket Pharmaceuticals5.99-0.68 (-10.2%)